Head to head
Elevance Health vs UnitedHealth
Side-by-side on the measures that matter, with a plain-English read. Full detail: ELV · UNH
ELV
Elevance Health
410.95-0.80%
1-year price shape — +33% over the period
Quant Rating C · 65/100
vs
UNH
UnitedHealth
376.90+0.45%
1-year price shape — +15% over the period
Quant Rating C · 42/100
UnitedHealth edges it on the scoreable measures. UnitedHealth pays the highest dividend yield.
| ELV | UNH | |
|---|---|---|
| Snapshot | ||
| Sector | Healthcare Plans | -- |
| Last price | 410.95 | 376.90 |
| Change today | -0.80% | +0.45% |
| 1-year return | +32.7% | +14.9% |
| Market cap | $89.12B | $338.30B |
| 52-week range | 270.87 – 434.35 | 252.95 – 458.79 |
| Valuation | ||
| P/E (TTM) | 18.18 | 24.22 |
| P/E percentile, own 5-yr range | 58th | 46th |
| P/B | 1.99 | 3.44 |
| Dividend yield | 1.67% | 2.37% |
| Profitability & growth | ||
| EPS (TTM) | 25.21 | 13.23 |
| Net profit (TTM) | $5.47B | $11.88B |
| Revenue (TTM) | $201.11B | $450.13B |
| Revenue growth (YoY) | +1.4% | +0.4% |
| Gross margin | -- | 19.5% |
| Operating margin | -- | 4.8% |
| Net margin | 2.5% | 3.1% |
| Free cash flow (TTM) | $6.29B | $23.62B |
| Ownership & sentiment | ||
| Institutional ownership | 95.6% | 89.3% |
| Insider activity (12mo) | 11 buy / 4 sell | 16 buy / 4 sell |
| Short interest (% of float) | 2.5% | 1.7% |
| Analyst consensus | 65% buy / 35% hold (17) | 81% buy / 19% hold (21) |
| Analyst price target | $450 (+10%) | $487 (+29%) |
| StockVane view | ||
| StockVane Quant Rating | C (65) | C (42) |
| Company | ||
| Employees | 97,100 | 390,000 |
| Founded | 1944 | -- |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.